Experience

BioMAdvanced Diagnostics

• France
• Medical Device
• 1 - 100 Employee

• Co-Founder & Chief Technology Advisor | Disrupting the Field of Immune System Related Biomarkers

  • Sep 2021 - Present

  About BioMAdvanced Diagnostics : Biotech/MedTech start-up based in Nantes, spinoff from the CRTI laboratory (UMR 1064, INSERM - University of Nantes) and the University Hospital (CHU) of Nantes, aims to offer companion molecular diagnostic tests and biomarkers in connection with the immune response of patients. The first applications will concern: 1) improving the follow-up of patients who have received a kidney or lung transplant, 2) determining the best drug to administer to… Show more About BioMAdvanced Diagnostics : Biotech/MedTech start-up based in Nantes, spinoff from the CRTI laboratory (UMR 1064, INSERM - University of Nantes) and the University Hospital (CHU) of Nantes, aims to offer companion molecular diagnostic tests and biomarkers in connection with the immune response of patients. The first applications will concern: 1) improving the follow-up of patients who have received a kidney or lung transplant, 2) determining the best drug to administer to patients with ulcerative colitis (UC). These tests are designed to be integrated into standard diagnostic and treatment protocols, easy to use by staff caring for targeted patients. Predictive scores are produced using algorithms based on the combination of signatures from the expression of selected genes and clinical parameters. www.biomadvanced-diagnostics.com Show less About BioMAdvanced Diagnostics : Biotech/MedTech start-up based in Nantes, spinoff from the CRTI laboratory (UMR 1064, INSERM - University of Nantes) and the University Hospital (CHU) of Nantes, aims to offer companion molecular diagnostic tests and biomarkers in connection with the immune response of patients. The first applications will concern: 1) improving the follow-up of patients who have received a kidney or lung transplant, 2) determining the best drug to administer to… Show more About BioMAdvanced Diagnostics : Biotech/MedTech start-up based in Nantes, spinoff from the CRTI laboratory (UMR 1064, INSERM - University of Nantes) and the University Hospital (CHU) of Nantes, aims to offer companion molecular diagnostic tests and biomarkers in connection with the immune response of patients. The first applications will concern: 1) improving the follow-up of patients who have received a kidney or lung transplant, 2) determining the best drug to administer to patients with ulcerative colitis (UC). These tests are designed to be integrated into standard diagnostic and treatment protocols, easy to use by staff caring for targeted patients. Predictive scores are produced using algorithms based on the combination of signatures from the expression of selected genes and clinical parameters. www.biomadvanced-diagnostics.com Show less



INSERM

• France
• Research Services
• 700 & Above Employee

• Associate Researcher

  • Sep 2015 - Present



Team for the Planet

• France
• Non-profit Organizations
• 700 & Above Employee

• Actionnaire

  • Sep 2022 - Present

  Time for the Planet®: Entrepreneurship at the service of climate emergency! join-time.com/en Time for the Planet®: Entrepreneurship at the service of climate emergency! join-time.com/en



King's College London

• United Kingdom
• Research Services
• 700 & Above Employee

• Postdoctoral Research Associate

  • Sep 2012 - Jun 2015

  Institute of Liver Sciences Institute of Liver Sciences



CR2TI UMR 1064 Nantes

• France
• Research Services
• 1 - 100 Employee

• Postdoctoral fellow

  • Nov 2011 - Aug 2012

  Deciphering the role of miR-142-3p in a negative feedback loop involving TGF-β signaling expression in B cells of drug-free kidney transplant recipients

• Engineer/ PhD student

  • Oct 2007 - Oct 2011

  Thesis subject: microRNA profiling in blood from renal transplanted patients. The aim of this thesis is to understand the mechanisms and to identify new biomarkers of spontaneous operational tolerance and chronic rejection in renal transplanted patients.



Microarray plateform -Nantes

• Engineer

  • Apr 2005 - Sep 2007

  expert assistance, experimental adjustment and technological watch regarding gene expression microarrays (Agilent, Amersham and home-made microarrays) expert assistance, experimental adjustment and technological watch regarding gene expression microarrays (Agilent, Amersham and home-made microarrays)